X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (204) 204
humans (203) 203
female (202) 202
oncology (106) 106
middle aged (101) 101
adult (97) 97
obstetrics & gynecology (64) 64
aged (61) 61
cancer (58) 58
pregnancy (49) 49
ovarian cancer (48) 48
ovarian neoplasms - pathology (44) 44
cell line, tumor (43) 43
expression (35) 35
cervical cancer (33) 33
prognosis (32) 32
immunohistochemistry (31) 31
carcinoma (30) 30
tumors (30) 30
aged, 80 and over (28) 28
chemotherapy (27) 27
pathology (27) 27
apoptosis (25) 25
ovarian neoplasms - genetics (25) 25
neoplasm staging (24) 24
research (24) 24
reverse transcriptase polymerase chain reaction (24) 24
analysis (23) 23
ovarian neoplasms - metabolism (23) 23
women (22) 22
animals (21) 21
blotting, western (21) 21
breast-cancer (21) 21
cell proliferation (21) 21
adolescent (20) 20
hong kong (20) 20
polymerase chain reaction (20) 20
uterine cervical neoplasms - virology (20) 20
abridged index medicus (19) 19
gene expression regulation, neoplastic (19) 19
obstetrics and gynecology (19) 19
research article (19) 19
signal transduction (18) 18
endometrial cancer (17) 17
health aspects (17) 17
neoplasm invasiveness (17) 17
ovarian neoplasms - drug therapy (17) 17
uterine neoplasms - pathology (17) 17
survival (16) 16
young adult (16) 16
endometrial neoplasms - pathology (15) 15
genetic aspects (15) 15
human papillomavirus (15) 15
hydatidiform mole (15) 15
mice (15) 15
uterine cervical neoplasms - pathology (15) 15
diagnosis (14) 14
dna methylation (14) 14
gestational trophoblastic disease (14) 14
retrospective studies (14) 14
risk factors (14) 14
treatment outcome (14) 14
cervical-cancer (13) 13
choriocarcinoma (13) 13
gene expression (13) 13
risk (13) 13
care and treatment (12) 12
gestational trophoblastic disease - pathology (12) 12
medicine (12) 12
promoter regions, genetic (12) 12
uterine cervical neoplasms - genetics (12) 12
uterine cervical neoplasms - prevention & control (12) 12
cells (11) 11
down-regulation (11) 11
endometrial neoplasms - genetics (11) 11
follow-up studies (11) 11
kinases (11) 11
methylation (11) 11
ovarian carcinoma (11) 11
p53 (11) 11
papillomavirus infections (11) 11
proliferation (11) 11
prostate-cancer (11) 11
biochemistry & molecular biology (10) 10
cell migration (10) 10
choriocarcinoma - genetics (10) 10
development and progression (10) 10
disease progression (10) 10
disease-free survival (10) 10
gestational trophoblastic neoplasia (10) 10
hpv (10) 10
hydatidiform mole - genetics (10) 10
hydatidiform mole - pathology (10) 10
hysterectomy (10) 10
invasion (10) 10
metastasis (10) 10
mutation (10) 10
papillomaviridae - isolation & purification (10) 10
prospective studies (10) 10
proteins (10) 10
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Best Practice & Research Clinical Obstetrics & Gynaecology, ISSN 1521-6934, 11/2017, Volume 45, pp. 1 - 1
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 10/2010, Volume 107, Issue 43, pp. 18622 - 18627
Ovarian cancer is a lethal gynecological malignancy, and to improve survival, it is important to identify novel prognostic and therapeutic targets. In this... 
Cell growth | Hepatocytes | Epithelial cells | Cell nucleus | Cell lines | Cell adhesion | Cyclins | Ovarian cancer | Cancer | Tumors | Prognostic marker | Therapeutic target | SURVIVAL | METASTASIS | CYCLIN D1 | PHOSPHORYLATION | PROTEIN-KINASE | MULTIDISCIPLINARY SCIENCES | therapeutic target | FACTOR RECEPTOR | NUCLEAR-LOCALIZATION | prognostic marker | EPIDERMAL-GROWTH-FACTOR | ANCHORAGE-INDEPENDENT GROWTH | PAK4 | Cell Proliferation | Prognosis | Humans | Middle Aged | p21-Activated Kinases - antagonists & inhibitors | Ovarian Neoplasms - pathology | DNA Primers - genetics | Proto-Oncogene Proteins pp60(c-src) - physiology | Cell Nucleus - enzymology | Gene Knockdown Techniques | Ovarian Neoplasms - genetics | Base Sequence | Adult | Female | Receptor, Epidermal Growth Factor - physiology | Cytoplasm - enzymology | Gene Expression | p21-Activated Kinases - genetics | Signal Transduction | Neoplasm Invasiveness | Ovarian Neoplasms - enzymology | Animals | Mice, Nude | Cell Line, Tumor | Aged | Mice | p21-Activated Kinases - physiology | Enzyme Activation | Cell Movement | Cell proliferation | Genetic markers | Development and progression | Genetic aspects | Cancer invasiveness | Research | Genetic regulation | Identification and classification | Cell migration | Studies | Phosphorylation | Medical prognosis | Rodents | Metastasis | Kinases | Gene expression | Cell adhesion & migration | Index Medicus | Biological Sciences
Journal Article
Oncotarget, ISSN 1949-2553, 2014, Volume 5, Issue 4, pp. 944 - 958
Epithelial ovarian cancer is a highly lethal and aggressive gynecological malignancy. The high mortality rate is due in part to the fact that many advanced... 
Acquired chemoresistance | Epithelial ovarian cancer | JAG1-Notch1 | MiR-199b-5p | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2014, Volume 9, Issue 11, pp. e113478 - e113478
Aim: Deregulation of FOXM1 has been documented in various cancers. The aim of this study was to evaluate the role of FOXM1 in ovarian cancer tumorigenesis and... 
BREAST-CANCER | ACTIVATION | DIFFERENTIAL EXPRESSION | CARCINOGENESIS | INHIBITION | MULTIDISCIPLINARY SCIENCES | MITOTIC CATASTROPHE | CELL INVASION | DNA-DAMAGE | CENTROMERE-ASSOCIATED KINESIN | P53 | Immunohistochemistry | Paclitaxel - pharmacology | Prognosis | Follow-Up Studies | Apoptosis - drug effects | Humans | Ovarian Neoplasms - pathology | Drug Resistance, Neoplasm | Ovarian Neoplasms - mortality | Forkhead Transcription Factors - metabolism | Kinesin - genetics | Female | Forkhead Transcription Factors - antagonists & inhibitors | Antineoplastic Agents, Phytogenic - therapeutic use | Ovarian Neoplasms - drug therapy | Real-Time Polymerase Chain Reaction | Ovarian Neoplasms - diagnosis | Kaplan-Meier Estimate | Down-Regulation - drug effects | Forkhead Transcription Factors - genetics | Paclitaxel - therapeutic use | G2 Phase Cell Cycle Checkpoints | Disease-Free Survival | Cell Line, Tumor | Antineoplastic Agents, Phytogenic - pharmacology | Forkhead Box Protein M1 | Neoplasm Staging | Cell Movement | Cancer patients | Analysis | Patient outcomes | Paclitaxel | Tumor proteins | Ovarian cancer | Deregulation | Ovarian carcinoma | Transcription | p53 Protein | DNA damage | Chemoresistance | Homeostasis | Multivariate analysis | Cell adhesion & migration | Surgery | Penicillin | Cell cycle | Forkhead protein | Tumorigenesis | Bioinformatics | Deoxyribonucleic acid--DNA | Gynecology | Gene expression | Obstetrics | Survival | Patients | Pathology | Chemotherapy | Cell death | Experimental design | Medical prognosis | Mutation | Cell migration | Cancer | Apoptosis | Index Medicus | Deoxyribonucleic acid | DNA
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2012, Volume 7, Issue 1, pp. e30311 - e30311
Background: Programmed cell death 4 (PDCD4), originally identified as the neoplastic transformation inhibitor, was attenuated in various cancer types. Our... 
TRANSFORMATION | APOPTOSIS | PROTEIN | GENE | INITIATION-FACTOR 4A | BIOLOGY | PROGRAMMED-CELL-DEATH-4 | EUKARYOTIC TRANSLATION | HUMAN HEPATOCELLULAR-CARCINOMA | EXPRESSION | BINDING | RNA-Binding Proteins - genetics | Cell Proliferation | Humans | Ovarian Neoplasms - pathology | Phosphatidylinositol 3-Kinases - metabolism | Protein Transport - drug effects | Extracellular Signal-Regulated MAP Kinases - metabolism | Cell Movement - physiology | Ovarian Neoplasms - genetics | Cyclin-Dependent Kinase Inhibitor p27 - metabolism | Transfection | Tumor Suppressor Proteins - genetics | Apoptosis Regulatory Proteins - genetics | Cyclin-Dependent Kinase Inhibitor p21 - metabolism | Female | Ovarian Neoplasms - metabolism | Culture Media, Serum-Free - pharmacology | Proto-Oncogene Proteins c-akt - metabolism | Tumor Suppressor Proteins - metabolism | RNA-Binding Proteins - physiology | Neoplasm Invasiveness | PTEN Phosphohydrolase - metabolism | Down-Regulation - drug effects | Blotting, Western | Apoptosis Regulatory Proteins - metabolism | Tumor Suppressor Proteins - physiology | Cell Cycle - physiology | Cell Line, Tumor | Apoptosis Regulatory Proteins - physiology | RNA-Binding Proteins - metabolism | Medical research | Phosphatases | Medicine, Experimental | Biochemistry | Metastasis | Research | Protein kinases | Investigations | Ovarian cancer | Apoptosis | Cell proliferation | Transformation | Ovarian carcinoma | Leukocyte migration | Homology | AKT protein | Kinases | Metastases | Degradation | Cell growth | Compartments | Modulation | Cell cycle | Inhibition | Tensin | 1-Phosphatidylinositol 3-kinase | Studies | Inhibitors | Cell death | Proteasomes | Cell migration | PTEN protein | Cytoplasm | Cancer | Tumors | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2013, Volume 8, Issue 1, pp. e53597 - e53597
Journal Article
Carcinogenesis, ISSN 0143-3334, 9/2008, Volume 29, Issue 9, pp. 1742 - 1750
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2012, Volume 7, Issue 11, pp. e47201 - e47201
Despite being an essential vitamin, folate has been implicated to enhance tumor growth, as evidenced by reports on overexpression of folate receptor alpha (FR... 
METHYLATION | TRANSPORT | DIFFERENTIAL EXPRESSION | MULTIDISCIPLINARY SCIENCES | IN-VIVO | BINDING-PROTEIN | METHOTREXATE | E-CADHERIN | CARRIER GENE | DIETARY-FOLATE | FOLIC-ACID | Up-Regulation | Cell Proliferation | Cadherins - metabolism | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Ovarian Neoplasms - pathology | Reduced Folate Carrier Protein - metabolism | Ovarian Neoplasms - genetics | Young Adult | Neoplasm Invasiveness - pathology | Aged, 80 and over | Adult | Female | Ovarian Neoplasms - metabolism | Cadherins - genetics | Ovary - metabolism | Promoter Regions, Genetic | Ovary - pathology | RNA, Messenger - genetics | Reduced Folate Carrier Protein - genetics | Disease-Free Survival | Folate Receptor 1 - genetics | Folate Receptor 1 - metabolism | Cell Line, Tumor | Ovarian Neoplasms - therapy | Aged | Neoplasm Invasiveness - genetics | Cell proliferation | Ovarian carcinoma | mRNA | Kinases | E-cadherin | Folic acid | Ovarian cancer | Receptors | Cell growth | Vitamin B | DNA methylation | Territorial transfers | Deoxyribonucleic acid--DNA | Review boards | Vitamin deficiency | Breast cancer | Tumor cell lines | Gene expression | Patients | Pathology | Gene amplification | Cell lines | Epigenetics | Transporter | Cell migration | Cancer | Tumors | Index Medicus | Deoxyribonucleic acid | DNA
Journal Article
Oncogene, ISSN 0950-9232, 07/2018, Volume 37, Issue 29, pp. 3981 - 3997
Journal Article